Joy Joseph

Joy Joseph

Auto-generated profile, based on publicly available information

Joy Joseph

Free Radical Research Center and Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2012 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
Jacek ZielonkaJacek Zielonka
Jacek Zielonka
ASAdam Bartlomiej Sikora
Adam Bartlomiej Sikora
MHMicael Hardy
Micael Hardy
JJJoy Joseph
Joy Joseph
BDBrian P. Dranka
Brian P. Dranka
BKBalaraman Kalyanaraman
Balaraman Kalyanaraman

13 June 2013 in BMC Cancer
Verified
Journal Article
Open access
PDF file
GCGang Cheng
Gang Cheng
Jacek ZielonkaJacek Zielonka
Jacek Zielonka
DMDonna M McAllister
Donna M McAllister
AMAlexander Craig Mackinnon
Alexander Craig Mackinnon
JJJoy Joseph
Joy Joseph
BKBalaraman Kalyanaraman
Balaraman Kalyanaraman
Background: Recent research has revealed that targeting mitochondrial bioenergetic metabolism is a promising chemotherapeutic strategy. Key to successful implementation of this chemotherapeutic strategy is the use of new and improved mitochondria-targeted cationic agents that selectively inhibit energy metabolism in breast cancer cells, while exerting little or no long-term cytotoxic effect in normal cells. Methods: In this study, we investigated the cytotoxicity and alterations in bioenergetic metabolism induced by mitochondria-targeted vitamin E analog (Mito-chromanol, Mito-ChM) and its acetylated ester analog (Mito-ChMAc). Assays of cell death, colony formation, mitochondrial bioenergetic function, intracellular ATP levels, intracellular and tissue concentrations of tested compounds, and in vivo tumor growth were performed. Results: Both Mito-ChM and Mito-ChMAc selectively depleted intracellular ATP and caused prolonged inhibition of ATP-linked oxygen consumption rate in breast cancer cells, but not in non-cancerous cells. These effects were significantly augmented by inhibition of glycolysis. Mito-ChM and Mito-ChMAc exhibited anti-proliferative effects and cytotoxicity in several breast cancer cells with different genetic background. Furthermore, Mito-ChM selectively accumulated in tumor tissue and inhibited tumor growth in a xenograft model of human breast cancer. Conclusions: We conclude that mitochondria-targeted small molecular weight chromanols exhibit selective anti-proliferative effects and cytotoxicity in multiple breast cancer cells, and that esterification of the hydroxyl group in mito-chromanols is not a critical requirement for its anti-proliferative and cytotoxic effect.

23 October 2012 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
AGAnamitra Ghosh
Anamitra Ghosh
AKAnumantha Gounder Kanthasamy
Anumantha Gounder Kanthasamy
JJJoy Joseph
Joy Joseph
VAVellareddy Anantharam
Vellareddy Anantharam
PSPallavi Shrivastava
Pallavi Shrivastava
AKAnumantha Gounder Kanthasamy
Anumantha Gounder Kanthasamy
Background: Parkinson’s disease (PD) is a devastating neurodegenerative disorder characterized by progressive motor debilitation, which affects several million people worldwide. Recent evidence suggests that glial cell activation and its inflammatory response may contribute to the progressive degeneration of dopaminergic neurons in PD. Currently, there are no neuroprotective agents available that can effectively slow the disease progression. Herein, we evaluated the anti-inflammatory and antioxidant efficacy of diapocynin, an oxidative metabolite of the naturally occurring agent apocynin, in a pre-clinical 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD. Methods: Both pre-treatment and post-treatment of diapocynin were tested in the MPTP mouse model of PD. Diapocynin was administered via oral gavage to MPTP-treated mice. Following the treatment, behavioral, neurochemical and immunohistological studies were performed. Neuroinflammatory markers, such as ionized calcium binding adaptor molecule 1 (Iba-1), glial fibrillary acidic protein (GFAP), gp91phox and inducible nitric oxide synthase (iNOS), were measured in the nigrostriatal system. Nigral tyrosine hydroxylase (TH)-positive neurons as well as oxidative markers 3-nitrotyrosine (3-NT), 4-hydroxynonenal (4-HNE) and striatal dopamine levels were quantified for assessment of the neuroprotective efficacy of diapocynin. Results: Oral administration of diapocynin significantly attenuated MPTP-induced microglial and astroglial cell activation in the substantia nigra (SN). MPTP-induced expression of gp91phox and iNOS activation in the glial cells of SN was also completely blocked by diapocynin. Notably, diapocynin markedly inhibited MPTP-induced oxidative markers including 3-NT and 4-HNE levels in the SN. Treatment with diapocynin also significantly improved locomotor activity, restored dopamine and its metabolites, and protected dopaminergic neurons and their nerve terminals in this pre-clinical model of PD. Importantly, diapocynin administered 3 days after initiation of the disease restored the neurochemical deficits. Diapocynin also halted the disease progression in a chronic mouse model of PD. Conclusions: Collectively, these results demonstrate that diapocynin exhibits profound neuroprotective effects in a pre-clinical animal model of PD by attenuating oxidative damage and neuroinflammatory responses. These findings may have important translational implications for treating PD patients.

19 February 2010 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
SBSilvina Bartesaghi
Silvina Bartesaghi
JWJorge Wenzel
Jorge Wenzel
MTMadia Trujillo
Madia Trujillo
MLMarcos López
Marcos López
JJJoy Joseph
Joy Joseph
RRRafael Radi
Rafael Radi

1 January 1995 in Free Radical Research
Verified
Journal Article
Closed access
PDF file
NHNeil Hogg
Neil Hogg
RSRavinder J. Singh
Ravinder J. Singh
JJJoy Joseph
Joy Joseph
FNFrank Neese
Frank Neese
BKB. Kalyanaraman
B. Kalyanaraman
Nitric oxide reacts with nitronyl nitroxides (NNO) to form imino nitroxides (INO) and this transformation can be monitored using electron spin resonance spectroscopy. Recently, Akaike et al., reported that NNO such as 2-phenyl-4,4,5,5-tetramethylimidazoline-3-oxide-1-oxyl (PTIO) and its derivatives (e.g., carboxy-PTIO) react with nitric oxide (.NO) in a 1:1 stoichiometry forming 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl (PTI) or the respective product (e.g., carboxy-PTI) together with nitrite and nitrate (Akaike et al., Biochemistry 32, 827-332, 1993). In this paper, we reevaluate their results and show that the stoichiometry of the reaction between PTIO and .NO is 0.63 +/- 0.06:1.0. The reason for this discrepancy is due to an erroneous assumption by Akaike et al., that the stoichiometry for the reaction between .NO and O2 is 2:1 in aqueous solution. If the data reported by Akaike et al., were recalculated using a 4:1 stoichiometry established for the aqueous oxidation of .NO, the reaction between .NO and PTIO would give a stoichiometry of 0.5:1.0 in closer agreement with our data. We propose mechanism for the reaction between PTIO and .NO in aqueous solution. This mechanism predicts that the stoichiometry between carboxy-PTIO and .NO is dependent on the rate of generation of .NO and is 1:1 only at low rates of .NO generation (i.e., 10(-13) M/s). However the stoichiometry approaches 0.5:1.0 at higher rates of .NO production or when it is added as a bolus. The ratio between nitrite and nitrate also varies as a function of the rate of generation of .NO. The model agrees with previous experimental observations that the aqueous oxidation of .NO in air saturated solutions will exclusively form nitrite and predicts that .NO will only generate substantial amounts of nitrate if it is released at a rate less than 10(-17) M/s. This may have important consequences in cellular systems where the concentration of .NO is typically measured from nitrite production.

1 January 2013 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
RMRadosław Michalski
Radosław Michalski
Jacek ZielonkaJacek Zielonka
Jacek Zielonka
MHMicael Hardy
Micael Hardy
JJJoy Joseph
Joy Joseph
BKBalaraman Kalyanaraman
Balaraman Kalyanaraman